Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenues	$ 18,757	$ 48,852	$ 69,315	$ 95,520
Operating Expenses:
Costs of goods sold	7,068	4,064	16,921	31,030
Sales and marketing expenses	66,680	13,359	117,871	24,895
Professional fees	97,141	133,751	167,360	166,767
Research and development costs	34,639		58,481
Operating expenses	99,183	19,362	136,097	39,411
Depreciation and amortization	20,959	30,402	41,917	61,151
General and administrative	102,267	60,728	134,533	93,094
Total Operating Expenses	427,937	261,666	673,180	416,348
Net Loss from Operations	(409,180)	(212,814)	(603,865)	(320,828)
Other Income (Expense):
Gain on early extinguishment of debt			44,527
Settlement loss		(396,500)		(396,500)
Interest expense	(123,643)	(92,615)	(211,515)	(181,218)
Total Other Income (Expense)	(123,643)	(489,115)	(166,988)	(577,718)
Net Loss	(532,823)	(701,929)	(770,853)	(898,546)
Other comprehensive income:
Effect of foreign currency translation	(1,442)	(52)	(4,229)	2,787
Total Other comprehensive income	(1,442)	(52)	(4,229)	2,787
Comprehensive Loss	(534,265)	(701,981)	(775,082)	(895,759)
Preferred Stock Dividends	(53,014)	(38,820)	(114,591)	(77,160)
Comprehensive Loss Available for Common Stockholders	$ (587,279)	$ (740,801)	$ (889,673)	$ (972,919)
Net Loss Per Share
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted Average Shares Outstanding
Basic (in shares)	928,445,010	495,163,432	903,080,360	421,615,585
Diluted (in shares)	928,445,010	495,163,432	903,080,360	421,615,585